Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Press Release Service: GenEdit Announces Multiyear Collaboration and ...
GenEdit reels in $8.5M to tackle delivery for gene therapy, gene ...
GenEdit Announces Multiyear Collaboration and License Agreement with ...
GenEdit | Revolutionizing Genetic Medicines
GenEdit and Editas Medicine Enter into Exclusive License and ...
GenEdit expands research center in South Korea and grows the team ...
GenEdit and Sarepta to develop gene editing therapeutics for ...
CITRIS Foundry | GenEdit
The GenEdit Manual (Splash Screen)
I’m excited to share that I’ve joined GenEdit as Chief Business Officer ...
Genentech signs nanoparticle deal worth up to $644m with GenEdit ...
GenEdit Tackles "Delivery, Delivery, Delivery" with Up-to-$644M ...
Sarepta, GenEdit team up on genetic drugs for neuromuscular diseases
GenEdit Raises $26 Million to Support Nanoparticle Delivery Platform ...
GenEdit Closes $26 Million Series A | citybiz
GenEdit rebrands as BreezeBio, raises $60M for genetic drug R&D
GenEdit Collaborates with Genentech for Non-Viral Nanoparticle ...
Interested to Know What GenEdit and Editas Medicine Are Jointly Working ...
Biotechnology Startup GenEdit Raises $26 mln In Series A Funding - Grit ...
GenEdit | LinkedIn
GenEdit and Genentech partner for autoimmune diseases | bioSeedin ...
NanoGalaxyPlatform_Illustration1-Desktop | GenEdit
GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer to ...
GenEdit | The Org
NanoGalaxyPlatform_Illustration1-Mobile | GenEdit
I am excited to welcome J. Rodrigo Mora, MD, PhD to GenEdit as our new ...
Sam Wong - Scietist II at GenEdit | The Org
Sarepta and Genedit report early success in polymer nanoparticle ...
GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M ...
Blue Bear Ventures | GenEdit
CITRIS Foundry startup GenEdit raises $26M in series A funding - CITRIS ...
GenEdit and Genentech Discover Novel Nanoparticles for Autoimmune ...
Biotechnology Company GenEdit Raises $8,5M In A New Funding Round Led ...
サブクローニング不要で部位特異的変異導入が行えるキット | GenEdit Site-Directed DNA Mutagenesis Kit ...
Genedit - 2025 Funding Rounds & List of Investors - Tracxn
focus-v2 | GenEdit
We held an exciting GenEdit Day, which is a recurring event to gather ...
GenEdit on LinkedIn: #boardofdirectors #leadership #geneticmedicines # ...
GenEdit raises $24M, signs Genentech deal
What is Growth Strategy and Future Prospects of GenEdit Company ...
What is Brief History of GenEdit Company? – CanvasBusinessModel.com
GenEdit - Bow Capital
GenEdit aims to expand with gene therapy : 네이트 뉴스
GenEdit - Research Associate, In Vivo | Juliana Popovitz Drollinger, PhD
Suhasini Yellai - Scientist I at GenEdit | The Org
Genedit 2026 Company Profile: Valuation, Funding & Investors | PitchBook
Gopinath Tiruchinapally - Principal Scientist at GenEdit | The Org
DCVC | DCVC Bio leads GenEdit’s $8.5 Million Seed Round: Safe,…
Leading CDMO | Polymers, Lipids and Non-Viral Nano Carriers | Curapath
6.44亿美元！罗氏押注新型递送技术，开发自免疾病核酸药物 1月23日，GenEdit宣布与罗氏子公司基因泰克（Genentech）达成合作和 ...
100 Top Biotech Companies in San Francisco · April 2026 | F6S
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance ...
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
独自のデリバリー技術で遺伝子治療薬や細胞治療薬の実用化を後押しするGenEdit – TECHBLITZ
GenEdit, CRISPR
罗氏6.44亿美元押注！GenEdit完成2400万美元A1轮融资医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
6.44亿美元！GenEdit与基因泰克合作开发自身免疫病核酸药物医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Delivery Is One of the Biggest Challenges for Genetic Medicine. A New ...
GenEdit's nanoparticle delivery tech attracts Genentech partnership ...
BreezeBio banks $60M to make more precise genetic medicines | BioPharma ...
Liquidia - 2026 Company Profile, Team, Funding, Competitors ...
Foundry alum partners with Genentech for nonviral gene therapy delivery ...
Create a crisp logo for a new gene editing biotech company by Walter ...
BIOTECH (113) GenEdit: Hydrophilic Polymer Nanoparticle Platform for ...
Pharmaceutical Business Review International on LinkedIn: # ...
ITVF Investment Portfolio - Innovation and Technology Fund
진에딧, 시리즈B 3500만弗..“전달기술 ‘면역’ 본격확장” - 바이오스펙테이터
#is3na #genedit #biotechnology #pharma #rna | IS3NA Society
#genomdüzenleme #rna #biyoteknoloji #crispr #molekülerbiyoloji #bilim # ...
Newby Lab
Gold Nanoparticle-Mediated Gene Therapy
Derek Sloan - Vice President, Therapeutic Product And Process ...
GenEdit, a gene therapy development company, announced on the 14th that ...
Graphical representation of various nanosystems used in gene therapy ...
Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy ...
유전자 가위 치료제를 배달하는 스타트업, 진에딧(GENEDIT)을 소개합니다.
Korean scientist inspired by the ‘Genentech story’ brings technology to ...
An illustration of nanoparticles designed for gene therapy, showing ...
The applications of nanoparticles in gene delivery. Nanoparticle-based ...
Novel nanoparticle mimicking virus offers new route to gene therapy
Congratulations to Romu Corbau on his new role of Chief Scientific ...
1 Schematic illustration of nanoparticles used for gene therapy ...
미래에셋
[인터뷰] 진에딧 이근우 대표 "한계 돌파하는 유전자 치료제 개발, 이제 시작이다" - MIT 테크놀로지 리뷰 | MIT ...
진에딧, 제넨텍과 유전자 치료제 공동 연구 개발 | 서울경제
DSC Investment
速递｜非病毒递送技术＋基因编辑，新锐联手开发创新神经肌肉疾病疗法_腾讯新闻
医麦客 - 中国生物医药产业新媒体
WIB | Work in biotech
GenEdit, Inc. - BIO International Convention 2026
#tides #nanogalaxy #geneticmedicine #genetherapy #geneediting #dna #rna ...
Entrepreneurs - Bow Capital
유전질환 치료제 '진에딧', 2500만달러 투자유치 추진 - 딜사이트
_Logo.jpg){kind=logo}
/d10o6nnig0wrdw.cloudfront.net/04-06-2026/t_9eb6344981824909abcf103cb5a2aea8_name_The_Morning_Filter_Thumbnail___Monetary_Policy_scaled.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/7MB36TQXN5H2NCIATDIRVO3IZY.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/PEZ3F3UZ4NGLJKRW5QNWS6DLOE.png)
